The EMA announced on Thursday that Guillain-Barré syndrome will be one of the possible side effects of the J&J vaccine in the future.
The EMA announced on Thursday that Guillain-Barré Syndrome (GBS) would be considered possible side effect of the vaccine from the manufacturer Johnson & Johnsonis listed. After 108 such cases in connection with the Johnson vaccination had been registered worldwide (as of June 30, 2021), they now want to include a corresponding warning in the package insert.
“After evaluating the data, the committee believes a causal relationship between the vaccine and GBS is possible,” it said in a broadcast.
In addition, it had until June 30 – at 21 million to date vaccinations given – Also given one death among the 108 GBS cases reported.
What is GBS?
Guillain-Barré syndrome is a rare neurological one illness, in which your own immune system damages nerve cells, which in turn can cause pain, numbness and muscle weakness. In the worst cases, GBS can even lead to paralysis.
However, as has been suggested, most people make a full recovery from the disease.
Pay attention to symptoms
Although a J&J vaccination-related case of GBS is extremely rare, medical personnel are asked to look out for symptoms of Guillain-Barré syndrome. If the worst comes to the worst, an early diagnosis should be made and adequate treatment initiated.
Also vaccinated themselves are asked to monitor their health after vaccination. It should be especially on following symptoms be respected:
➤ Muscle weakness (limbs, chest, face)
➤ Visual disturbances
➤ Double vision and impaired eye mobility
➤ Coordination problems and unsteady walking
➤ Numbness or tingling in the feet, hands, arms
➤ Difficulty speaking, chewing or swallowing
➤ Breathing disorders
➤ Coordination problems